Synlogic CEO and Leadership

I am passionate about…drug development,novel platforms,the power of science to change lives,development of treatments for rare and neglected diseases,diversity and Inclusion,professional development and mentorship,STEM education

Antoine 'Tony' Awad is a Chief Operating Officer at SYNLOGIC, INC. and is based in Greater Boston Area. He has experience at MERRIMACK PHARMACEUTICALS INC and has worked as Head:Technical Operations at SYNLOGIC, INC.; Senior VP:Ops/Head:Manufacturing at Abpro; and Consultant at SYNLOGIC, INC.. Antoine works or has worked as SVP at L.E.A.F. Pharmaceuticals and Head of Process Sciences & Manufacturing at Merrimack College. He attended Boston University and NETikos.

As CSO, Dr. Hava leads the Research and Development organization in the development of iSPERSE dry powder delivery platform. In addition, Dr. Hava directs and manages the company’s therapeutic strategy to identify and prioritize drug targets and drugs that are enabled by the iSPERSE dry powder delivery platform. Dr. Hava joined Pulmatrix in 2006 as one of the first Senior Scientists and has been involved in the early stage research and development programs that identified and characterized several of the key aspects of the Pulmatrix technology. Dr. Hava earned his PhD. in Molecular Biology and Microbiology at Tufts University and completed his post-doctoral training studying immunology and host-pathogen interactions at Harvard Medical School. Dr. Hava has co-authored over 20 papers and abstracts focused on pulmonary infectious disease, immunology and chronic lung diseases.

I am passionate about…drug development,novel platforms,the power of science to change lives,development of treatments for rare and neglected diseases,diversity and Inclusion,professional development and mentorship,STEM education